Related Experiment Videos
[Problems in the development of immunoglobulin preparations].
1Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK, Bern, Schweiz.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1989
Summary
High-dose intravenous immunoglobulin (IVIG) preparations require enhanced safety and efficacy. Modern fractionation methods focus on eliminating anticomplementary aggregates and preserving native antibody function for improved IVIG treatments.
Area of Science:
- Biopharmaceutical manufacturing
- Immunology
- Protein chemistry
Context:
- High-dose intravenous immunoglobulin (IVIG) therapy demands stringent safety and efficacy standards for preparations.
- Early IVIG methods involved non-specific enzymatic or chemical modifications.
- Current advancements focus on specific removal of anticomplementary aggregates.
Purpose:
- To outline the evolving requirements for high-dose IVIG preparations.
- To discuss modern fractionation techniques for improved IVIG safety and efficacy.
- To emphasize the importance of preserving native immunoglobulin function.
Summary:
- Modern IVIG production utilizes mild fractionation methods, such as precipitation, adsorption, or acid treatment, to eliminate anticomplementary aggregates.
- Ensuring viral safety involves high plasma quality, appropriate fractionation, and Good Manufacturing Practice (GMP) measures.
- Maintaining the complete antibody spectrum in a native state is crucial for polyvalent immunoglobulin efficacy, necessitating fractionation methods that accommodate the broad isoelectric range of antibodies.
Impact:
- Optimized fractionation and purification processes enhance the safety and therapeutic efficacy of IVIG.
- Preserving the native physiological functions of immunoglobulin molecules ensures treatment effectiveness.
- Efficient production methods guarantee supply stability and cost-effectiveness for essential immunotherapies.